Work

The rate of novel actionable mutations in standard of care NGS panel testing in gastrointestinal malignancies.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.4_suppl.640

Authors: Amir Mehrvarz Sarshekeh, Jonathan Loree, Allan Andresson Lima Pereira, Kanwal Pratap Singh Raghav, Michael Lam, Shailesh M Advani, Jennifer S Davis, A. Dasari, Van Karlyle Morris, David Menter, Cathy Eng, Kenna Rael Shaw, Russell Broaddus, Mark Routbort, Rajyalakshmi Luthra, Dipen M. Maru, Michael J. Overman, Funda Meric-Bernstam, Scott Kopetz

Institutions: The University of Texas MD Anderson Cancer Center, Instituto do Câncer do Estado de São Paulo, Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy

Language: English

Topic: Cancer Genomics and Diagnostics

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2807157903

Cites:

Cited by:

Related to: 10